Two separate medical incidents at hospitals in Japan have resulted in patient deaths and serious injuries, raising urgent questions about medication safety protocols and patient care standards that affect all residents, including foreign nationals. In Chitose, Hokkaido, a nurse at the municipal hospital mistakenly administered the wrong medication to a male patient in his 90s earlier this month, according to NHK. The patient subsequently died, and hospital officials have acknowledged that "there is a high possibility that the incorrect medication led to the death." Reports indicate the nurse administered a cardiac medication instead of the intended pain relief drug. The hospital has apologized to the bereaved family and announced plans to establish a third-party investigation committee to examine the circumstances surrounding the fatal error. Meanwhile, a more complex situation has unfolded at Saitama Children's Medical Center in Saitama City, where multiple pediatric patients receiving leukemia treatment have been affected by what appears to be a systematic problem with intrathecal injections—a procedure where anti-cancer drugs are administered into the spinal canal area. According to NHK, one teenage patient has died, two others remain in critical condition and unconscious, and an additional two patients have developed neurological symptoms following the same type of treatment. The severity of the Saitama case has prompted immediate concern among medical professionals and families with children undergoing cancer treatment. Intrathecal chemotherapy is a standard procedure for certain types of leukemia, but it requires precise technique and correct medication preparation. Any errors in drug concentration, dosage, or administration method can result in severe neurological damage or death. For foreign residents in Japan, these incidents highlight several important considerations regarding medical care safety. First, while Japan's healthcare system is generally regarded as world-class, medical errors can and do occur, just as they do in hospitals worldwide. Patients and families should feel empowered to ask questions about medications being administered, request verification of drug names and dosages, and seek clarification about any procedures they don't understand. Language barriers can compound safety risks in medical settings. Expats who are not fluent in Japanese should consider bringing a Japanese-speaking friend or family member to important medical appointments, especially for complex treatments or hospital stays. Many larger hospitals in urban areas offer interpreter services, though availability varies by facility and language. It's advisable to inquire about interpretation services when scheduling treatments or procedures. Both hospitals involved have indicated they will conduct investigations and review their safety protocols. The Chitose Municipal Hospital's decision to include third-party experts in their investigation reflects a commitment to transparency, though details about preventive measures have not yet been announced. The Saitama Children's Medical Center has not yet released information about what may have caused the multiple adverse events. These incidents also underscore the importance of understanding patient rights in Japan. While medical culture in Japan traditionally emphasizes deference to medical professionals, patients have the right to informed consent, to understand their treatment plans, and to receive explanations about medications and procedures. Foreign residents should not hesitate to request detailed information about their care, even if it means asking for materials in English or requesting additional explanation time. For families with children receiving ongoing medical treatment, particularly for serious conditions like leukemia, these cases serve as a reminder to maintain open communication with medical teams, keep detailed records of treatments received, and report any unusual symptoms immediately. As investigations into both incidents continue, they represent a critical moment for examining medication safety protocols across Japan's healthcare system and ensuring that preventive measures are strengthened to protect all patients, regardless of age or nationality.